11 assets in Classic Familial Adenomatous Polyposis

Therapeutic assets addressing Classic Familial Adenomatous Polyposis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Celecoxib Classic Familial Adenomatous Polyposis	Yonsei University	P3	BB (65)
Metformin Classic Familial Adenomatous Polyposis	Yonsei University	P3	BB (64)
Sirolimus Classic Familial Adenomatous Polyposis	University Hospital, Toulouse	P3	B (62)
Lithium, Elemental Classic Familial Adenomatous Polyposis	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P2	B (57)
Obeticholic Acid Classic Familial Adenomatous Polyposis	National Cancer Institute (NCI)	P2	CCC (53)
Tpst-1495 Classic Familial Adenomatous Polyposis	National Cancer Institute (NCI)	P2	CCC (53)
Tegavivint Classic Familial Adenomatous Polyposis	HonorHealth Research Institute	P1/2	CCC (48)
Jnj-64251330 Classic Familial Adenomatous Polyposis	Janssen Research & Development, LLC	P1	CC (47)
Dordaviprone Classic Familial Adenomatous Polyposis	National Cancer Institute (NCI)	P1	C (39)
Rec-4881 Classic Familial Adenomatous Polyposis	Recursion Pharmaceuticals Inc.	P2	NR ()
Vitamin B-1 Classic Familial Adenomatous Polyposis	Shanghai Zhongshan Hospital	N/A	NR ()